News
-
-
-
-
-
PRESS RELEASE
Le virus oncolytique BT-001 de Transgene et BioInvent montre une activité antitumorale prometteuse dans l’étude en cours de Phase I/IIa dans les tumeurs solides résistantes
Le virus oncolytique BT-001 de Transgene et BioInvent montre une activité antitumorale prometteuse dans une étude en cours de Phase I/IIa sur les tumeurs solides résistantes, présentant des premiers signes d'efficacité en combinaison avec KEYTRUDA -
PRESS RELEASE
Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
Transgene and BioInvent present promising early results of oncolytic virus BT-001 in ESMO 2024, showing antitumor activity in solid tumors. BT-001 induces tumor regression and enhances T cell infiltration -
PRESS RELEASE
Rektron Announces Successful IPO and Begins Trading on the Canadian Securities Exchange, Frankfurt Stock Exchange and Tradegate Exchange and Corporate Updates
Rektron Group Inc. successfully completes IPO on CSE, FSE, and TE. Appoints new COO and receives requisition for a special meeting. Engages MACA and ITG for market services -
PRESS RELEASE
bettermoo(d) Receives Initial Purchase Orders from UNFI Canada and West Coast Distributor for Moodrink Barista(TM) to Target Retail and Coffee Industry
bettermoo(d) announces initial purchase orders for Moodrink Barista™ from UNFI Canada and West Coast Coffee Shop Distributor, aiming to expand market presence in the growing North American coffee industry -
-
